Gustavo Laham

Gustavo Laham

Auto-generated profile, based on publicly available information

Gustavo Laham

Department of Nephrology, CEMIC University Hospital, Buenos Aires, Argentina

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Transplantation
Verified
Journal Article
Closed access
GLGustavo Laham
Gustavo Laham
GPGervasio Soler Pujol
Gervasio Soler Pujol
AVAntonio Vilches
Antonio Vilches
ACAna Cusumano
Ana Cusumano
CDCarlos Diaz
Carlos Diaz
In incident hemodialysis (HD) patients the use of catheters is associated with a worse prognosis when compared to those with an arteriovenous fistula (AVF), but the role of vascular access (VA) type in the morbidity and mortality of patients returning to HD with a failing renal allograft is unknown. We aimed to determine the associations between the type of vascular access and mortality in this population. This was a retrospective observational cohort study of 138 patients who initiated dialysis after kidney transplant failure between 1995 and 2014. We recorded access type, laboratory values at entry, stratified patients per risk and determined the effect on mortality of programmed vascular access (PVA), (AVF or PTFE graft) and nonprogrammed vascular access (UPVA), (tunneled or nontunneled catheters) at the initiation of HD. 85 (61.6 %) and 53 (38.4 %) patients initiated therapy with PVA and UPVA, respectively. Overall mortality was 14.6 % at 1 year. Patients using catheters had greater mortality than those with a PVA (Log Rank p value <0.0001). At 24 months 7 patients died in PVA group vs. 22 in UPVA group. Multivariate Cox analysis showed that initiation of HD with a catheter (hazard ratio (HR), 5.90; 95 %, confidence interval (CI) 2.83 to 12.31) was independently associated with greater mortality after adjusting for confounders. Nonprogrammed vascular access with a catheter predicted all cause mortality among patients with transplant failure reentering HD.

21 June 2023 in Frontiers in Medicine
Verified
Journal Article
Open access
JSJihan Sleiman
Jihan Sleiman
GPGervasio Soler Pujol
Gervasio Soler Pujol
EMErika Montañez
Erika Montañez
VRVeronica Roatta
Veronica Roatta
GLGustavo Laham
Gustavo Laham
Sex and gender are often used as synonyms. However, while sex describes only a biological state, gender is a dynamic concept that takes into account psychosocial and cultural aspects of human existence that can change according to place and time. Inequality in medicine has been described in several areas. Among them, gender inequality has been disregarded for many years and is now a matter of concern. Chronic kidney disease (CKD) is a growing epidemic worldwide, affecting approximately 10% of the population. Although both men and women are affected, gender equality, especially in access to different treatments, is a matter of concern. We decided to investigate gender equality in patients with CKD. To this end, we conducted a literature narrative review to determine whether gender inequalities were found in CKD patients in general and in access to different treatment modalities in particular. A non-language restricted search was performed until November 30th 2022 in PubMed, SciELO, Trip Database, Google Scholar, MEDES y MEDLINE. We also investigated the situation in this regard in our country. We found that CKD is more prevalent in women than men, nevertheless this prevalence decreases along the CKD stages to the point that more men reach end stage kidney disease (ESKD) and dialysis. Access to transplant (ATT) is higher in men than in women although posttransplant survival shows no gender differences. Finally, most series have shown that women are more frequently Kidney transplantation (KT) living donors than men. Results in our country are similar to the published literature with the exception of a higher proportion of men as KT living donors. As in other areas, gender inequality in Nephrology has been largely overlooked. In this review we have highlighted gender differences in CKD patients. Gender inequality in Nephrology exists and needs to be looked upon in order to reach a personalized clinical approach.

11 March 2024 in Viruses
Verified
Journal Article
Open access
PDF file
NRNoelia Soledad Reyes
Noelia Soledad Reyes
PSPietro Giorgio Spezia
Pietro Giorgio Spezia
RJRaquel Jara
Raquel Jara
FFFabio Filippini
Fabio Filippini
NBNatalia Boccia
Natalia Boccia
MEMarcela Echavarria
Marcela Echavarria
Torque Teno Virus (TTV) is a nonpathogenic and ubiquitous ssDNA virus, a member of the Anelloviridae family. TTV has been postulated as a biomarker in transplant patients. This study aimed to determine the TTV species diversity and variability in renal transplant recipients and to associate species diversity with the corresponding TTV viral load. From 27 recipients, 30 plasma samples were selected. Viral load was determined using two real-time PCR assays, followed by RCA-NGS and ORF1 phylogenetic analysis. The TTV diversity was determined in all samples. Variability was determined in three patients with two sequential samples (pre- and post-transplantation). Most of the samples presented multiple TTV species, up to 15 different species were detected. In the pre-transplant samples (n = 12), the most prevalent species were TTV3 (75%) and TTV13 (75%), and the median number of species per sample was 5 (IQR: 4–7.5). TTV3 was also the most prevalent (56%) in the post-transplant samples (n = 18), and the median number of species was 2 (IQR: 1.8–5.5). No significant correlation between the number of species and viral load was found. The number and type of TTV species showed total variability over time. We report high TTV species diversity in Argentinian recipients, especially in pre-transplant period, with total intra-host variability. However, we found no significant correlation between this high diversity and TTV viral load.

1 January 2010 in Transplantation Proceedings
Verified
Journal Article
Closed access
GLG. Laham
G. Laham
SSS. Sleiman
S. Sleiman
GPG. Soler Pujol
G. Soler Pujol
CDC. Diaz
C. Diaz
MDM. Dávalos
M. Dávalos
AVA. Vilches
A. Vilches

22 June 2020 in Clinical Transplantation
Verified
Journal Article
Closed access
PDF file
LBLiliana Bisigniano
Liliana Bisigniano
GLGustavo Laham
Gustavo Laham
MGMaria Cora Giordani
Maria Cora Giordani
VTViviana Tagliafichi
Viviana Tagliafichi
DKDaniela Hansen Krogh
Daniela Hansen Krogh
GRGuillermo Javier Rosa‐Diez
Guillermo Javier Rosa‐Diez

Verified
Journal Article
Open access
PDF file
RDRaquel Diaz
Raquel Diaz
PSPilar Sandoval
Pilar Sandoval
Raul Rodrigues-DiezRaul Rodrigues-Diez
Raul Rodrigues-Diez
GPGloria del Peso
Gloria del Peso
JJJosé A Jiménez-Heffernan
José A Jiménez-Heffernan
RSRafael Selgas
Rafael Selgas
Peritoneal hyalinizing vasculopathy (PHV) represents the cornerstone of long-term peritoneal dialysis (PD), and especially characterizes patients associated with encapsulating peritoneal sclerosis. However, the mechanisms of PHV development remain unknown. A cross sectional study was performed in 100 non-selected peritoneal biopsies of PD patients. Clinical data were collected and lesions were evaluated by immunohistochemistry. In selected biopsies a microRNA (miRNA)-sequencing analysis was performed. Only fifteen patients (15%) showed PHV at different degrees. PHV prevalence was significantly lower among patients using PD fluids containing low glucose degradation products (GDP) (5.9% vs. 24.5%), angiotensin converting enzyme inhibitors (ACEIs) (7.5% vs. 23.4%), statins (6.5% vs. 22.6%) or presenting residual renal function, suggesting the existence of several PHV protective factors. Peritoneal biopsies from PHV samples showed loss of endothelial markers and induction of mesenchymal proteins, associated with collagen IV accumulation and wide reduplication of the basement membrane. Moreover, co-expression of endothelial and mesenchymal markers, as well as TGF-β1/Smad3 signaling activation were found in PHV biopsies. These findings suggest that an endothelial-to-mesenchymal transition (EndMT) process was taking place. Additionally, significantly higher levels of miR-7641 were observed in severe PHV compared to non-PHV peritoneal biopsies. Peritoneal damage by GDPs induce miRNA deregulation and an EndMT process in submesothelial vessels, which could contribute to collagen IV accumulation and PHV.